NeuMoDx Molecular Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- NeuMoDx Molecular's estimated annual revenue is currently $18.6M per year.
- NeuMoDx Molecular received $20.0M in venture funding in May 2016.
- NeuMoDx Molecular's estimated revenue per employee is $251,000
- NeuMoDx Molecular has 74 Employees.
- NeuMoDx Molecular grew their employee count by 28% last year.
- NeuMoDx Molecular currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Pricing|
|CFI Medical Sol...||$7M||28||N/A||N/A||N/A|
|Art Optical Con...||$6.3M||25||N/A||N/A||N/A|
What Is NeuMoDx Molecular?
Number of Employees
Employee Growth %
|Jeff Williams||CEO/Chairman||Email Available|
|Sundu Brahmasandra||President and COO, NeuMoDx Molecular||Email Available|
|Jeff Williams||Chairman and CEO||Email Available|
|Manjeet Sandhu||Business Development Manager||Email Available|
|John Neisser||Business Development Manager at NeuMoDx Molecular||Email Available|
|Dawn Winder||Sr. Director of Quality||Email Available|
|Dan Harma||Chief Commercial Officer||Email Available|
|Marlo Ives||Reagent Production Manager||Email Available|
|Dominick Pennella||Director Of Customer Services||Email Available|
|Jennifer Ruth||Clinical Affairs Manager||Email Available|
NeuMoDx Molecular News
NEW YORK – NeuMoDx has filed a response with the District of ... by Becton Dickinson that the molecular diagnostics developer infringed on ...
126.96.36.199.1.1 Lab-on-a-chip and Molecular Biology ... Cancer Therapy; QIAGEN NV Selects NeuMoDx Molecular, Inc for CE-IVD Assays Purchase ...
BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced an expansion ...
NeuMoDx Molecular Funding